Hyperion Defi Inc 's

• HYPD's Stock Performance relative to its Competitors

Ocular Therapeutix Inc Share Performance -16.77% One Year

Ocular Therapeutix Inc Profile Ocular Therapeutix Inc is a biopharmaceutical company that focuses on developing and commercializing innovative therapies for diseases and conditions of the eye. They utilize their proprietary hydrogel technology to design and manufacture sustained-release treatments that can be administered during routine eye exams and eliminate the need for patient compliance with eye drops. More about Ocular Therapeutix Inc 's Market Share

Oculis Holding Ag Share Performance -39.60% This Year

Oculis Holding Ag Profile Oculis Holding Ag is a pharmaceutical company that specializes in developing and commercializing innovative ophthalmic treatments. Their business model revolves around conducting in-depth research and development to formulate eye medications that target various ocular diseases. They then seek regulatory approvals and form strategic partnerships to manufacture and distribute their products globally, aiming to improve eye health and provide effective treatment options for patients. More about Oculis Holding Ag's Market Share

Kiora Pharmaceuticals Inc Share Performance -8.42% One Year

Kiora Pharmaceuticals Inc Profile Kiora Pharmaceuticals Inc operates with a business model focused on the research, development, and commercialization of innovative pharmaceutical products for various medical conditions and diseases. The company aims to create value through the discovery of new drugs, rigorous clinical trials, and strategic partnerships for ultimate patient benefit and sustainable growth. More about Kiora Pharmaceuticals Inc 's Market Share

Korn Ferry Share Performance +20.96% This Quarter

Korn Ferry Profile Korn Ferry's business model revolves around providing consulting services and talent management solutions to organizations worldwide. More about Korn Ferry's Market Share

Kala Bio inc Share Performance -35.18% Over The Past 5 Days

Kala Bio inc Profile Kala Pharmaceuticals Inc operates on a business model that revolves around the development and commercialization of innovative ophthalmic therapeutics to address unmet needs in eye care. Their approach focuses on utilizing their proprietary mucus-penetrating particle (MPP) technology to enhance drug delivery and improve patient outcomes. By leveraging partnerships and collaborations with industry stakeholders, Kala Pharmaceuticals aims to bring novel therapies to market and improve the standard of care for various eye diseases. More about Kala Bio inc 's Market Share

Sources: Hyperion Defi inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Thursday, August 20, 2026 3:20 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Hyperion Defi inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.